| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor activity | 8.21e-11 | 22 | 134 | 7 | GO:0004993 | |
| GeneOntologyMolecularFunction | G protein-coupled amine receptor activity | 2.64e-10 | 41 | 134 | 8 | GO:0008227 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | XCR1 HTR1B HTR1D GPR18 HTR1E HTR1F MRGPRE GPR84 OR2J3 GPR101 CHRM2 CHRM5 ADRA1A CXCR6 GPR158 OR51Q1 MRGPRG HRH2 CCR1 CCR5 GPRC5D TAS2R45 TAS2R43 TAS2R50 CNR2 | 9.13e-10 | 884 | 134 | 25 | GO:0004930 |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | GABRG2 HTR1B HTR1D HTR1E HTR1F GRIK4 CHRM2 CHRM5 GPR158 HRH2 | 1.37e-09 | 100 | 134 | 10 | GO:0030594 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | GABRG2 ABCC3 CACNA2D1 HTR1B CACNA2D2 ABCA13 SPNS2 SLC25A14 GRIK4 PKD1L2 SLC44A4 CHRM5 ABCC6 SLC5A2 ABCB4 SLC6A9 SLC9C1 PIEZO2 SLC50A1 SLC18A1 SLC22A14 SV2C SLC38A11 SLC45A1 STRA6 SLC37A4 SLC27A4 SLC22A31 | 3.89e-09 | 1180 | 134 | 28 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | GABRG2 ABCC3 CACNA2D1 HTR1B CACNA2D2 ABCA13 SPNS2 SLC25A14 GRIK4 ATP8B1 PKD1L2 SLC44A4 CHRM5 ABCC6 SLC5A2 ABCB4 SLC6A9 SLC9C1 PIEZO2 SLC50A1 SLC18A1 SLC22A14 SV2C SLC38A11 SLC45A1 STRA6 SLC37A4 SLC27A4 SLC22A31 | 6.44e-09 | 1289 | 134 | 29 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GABRG2 XCR1 HTR1B HTR1D GPR18 HTR1E HTR1F MRGPRE GPR84 OR2J3 GRIK4 GPR101 CHRM2 CHRM5 IFNLR1 LRP8 ADRA1A CXCR6 GPR158 OR51Q1 MRGPRG HRH2 CCR1 CCR5 GPRC5D TAS2R45 TAS2R43 TAS2R50 CNR2 | 1.89e-08 | 1353 | 134 | 29 | GO:0004888 |
| GeneOntologyMolecularFunction | serotonin binding | 1.32e-06 | 13 | 134 | 4 | GO:0051378 | |
| GeneOntologyMolecularFunction | amine binding | 1.06e-05 | 21 | 134 | 4 | GO:0043176 | |
| GeneOntologyMolecularFunction | C-C chemokine receptor activity | 1.56e-05 | 23 | 134 | 4 | GO:0016493 | |
| GeneOntologyMolecularFunction | C-C chemokine binding | 1.86e-05 | 24 | 134 | 4 | GO:0019957 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phospholipase C activity | 2.58e-05 | 26 | 134 | 4 | GO:0004435 | |
| GeneOntologyMolecularFunction | G protein-coupled chemoattractant receptor activity | 2.58e-05 | 26 | 134 | 4 | GO:0001637 | |
| GeneOntologyMolecularFunction | chemokine receptor activity | 2.58e-05 | 26 | 134 | 4 | GO:0004950 | |
| GeneOntologyMolecularFunction | mannosyltransferase activity | 3.50e-05 | 28 | 134 | 4 | GO:0000030 | |
| GeneOntologyMolecularFunction | phospholipase C activity | 4.04e-05 | 29 | 134 | 4 | GO:0004629 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GABRG2 ABCC3 CACNA2D1 HTR1B CACNA2D2 SLC25A14 GRIK4 PKD1L2 CHRM5 ABCC6 SLC5A2 SLC6A9 SLC9C1 SLC18A1 SLC45A1 SLC37A4 | 4.97e-05 | 758 | 134 | 16 | GO:0015318 |
| GeneOntologyMolecularFunction | chemokine binding | 6.82e-05 | 33 | 134 | 4 | GO:0019956 | |
| GeneOntologyMolecularFunction | G protein-coupled neurotransmitter receptor activity | 8.05e-05 | 13 | 134 | 3 | GO:0099528 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCC3 ABCA13 SLC25A14 SLC44A4 ABCC6 SLC5A2 ABCB4 SLC6A9 SLC9C1 SLC18A1 SLC45A1 SLC37A4 | 9.09e-05 | 477 | 134 | 12 | GO:0022804 |
| GeneOntologyMolecularFunction | glucoside transmembrane transporter activity | 1.34e-04 | 3 | 134 | 2 | GO:0042947 | |
| GeneOntologyMolecularFunction | chemokine (C-C motif) ligand 5 binding | 1.34e-04 | 3 | 134 | 2 | GO:0071791 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.57e-04 | 171 | 134 | 7 | GO:0015103 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 3.25e-04 | 49 | 134 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 3.62e-04 | 196 | 134 | 7 | GO:0005319 | |
| GeneOntologyMolecularFunction | dolichyl-diphosphooligosaccharide-protein glycotransferase activity | 4.41e-04 | 5 | 134 | 2 | GO:0004579 | |
| GeneOntologyMolecularFunction | oligosaccharyl transferase activity | 4.41e-04 | 5 | 134 | 2 | GO:0004576 | |
| GeneOntologyMolecularFunction | cytokine receptor activity | 4.96e-04 | 97 | 134 | 5 | GO:0004896 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 6.63e-04 | 59 | 134 | 4 | GO:1901505 | |
| GeneOntologyMolecularFunction | bitter taste receptor activity | 7.68e-04 | 27 | 134 | 3 | GO:0033038 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DHX36 ABCC3 SPG7 ABCA13 RNF213 ATP8B1 ABCC6 DHX9 ABCB4 SMARCA4 | 7.96e-04 | 441 | 134 | 10 | GO:0016887 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | ABCC3 GRIK4 SLC44A4 SLC6A9 SLC22A14 SLC38A11 SLC37A4 SLC27A4 | 8.25e-04 | 293 | 134 | 8 | GO:0008514 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC25A14 SLC44A4 SLC5A2 SLC6A9 SLC9C1 SLC18A1 SLC45A1 SLC37A4 | 8.82e-04 | 296 | 134 | 8 | GO:0015291 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GABRG2 CACNA2D1 HTR1B CACNA2D2 SLC25A14 GRIK4 PKD1L2 CHRM5 SLC5A2 SLC6A9 SLC9C1 PIEZO2 SLC18A1 SLC45A1 | 9.01e-04 | 793 | 134 | 14 | GO:0015075 |
| GeneOntologyMolecularFunction | G protein-coupled acetylcholine receptor activity | 9.18e-04 | 7 | 134 | 2 | GO:0016907 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 9.50e-04 | 29 | 134 | 3 | GO:0051119 | |
| GeneOntologyMolecularFunction | phospholipase activity | 1.03e-03 | 114 | 134 | 5 | GO:0004620 | |
| GeneOntologyMolecularFunction | ABC-type glutathione S-conjugate transporter activity | 1.22e-03 | 8 | 134 | 2 | GO:0015431 | |
| GeneOntologyMolecularFunction | dolichyl-phosphate-mannose-protein mannosyltransferase activity | 1.22e-03 | 8 | 134 | 2 | GO:0004169 | |
| GeneOntologyMolecularFunction | phosphatidylcholine floppase activity | 1.22e-03 | 8 | 134 | 2 | GO:0090554 | |
| GeneOntologyMolecularFunction | taste receptor activity | 1.39e-03 | 33 | 134 | 3 | GO:0008527 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 1.52e-03 | 34 | 134 | 3 | GO:0042910 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 1.63e-03 | 75 | 134 | 4 | GO:0098960 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA2D1 HTR1B CACNA2D2 SLC25A14 GRIK4 PKD1L2 SLC5A2 SLC6A9 SLC9C1 PIEZO2 SLC18A1 SLC45A1 | 1.74e-03 | 664 | 134 | 12 | GO:0008324 |
| GeneOntologyMolecularFunction | vitamin transmembrane transporter activity | 1.79e-03 | 36 | 134 | 3 | GO:0090482 | |
| GeneOntologyMolecularFunction | double-stranded RNA binding | 1.88e-03 | 78 | 134 | 4 | GO:0003725 | |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 1.94e-03 | 10 | 134 | 2 | GO:0043225 | |
| GeneOntologyMolecularFunction | lipase activity | 2.40e-03 | 138 | 134 | 5 | GO:0016298 | |
| GeneOntologyMolecularFunction | antiporter activity | 2.40e-03 | 138 | 134 | 5 | GO:0015297 | |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 2.80e-03 | 42 | 134 | 3 | GO:0015144 | |
| GeneOntologyMolecularFunction | nuclear export signal receptor activity | 2.82e-03 | 12 | 134 | 2 | GO:0005049 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DHX36 ABCC3 SPG7 ABCA13 RNF213 ATP8B1 ABCC6 DHX9 ABCB4 SMARCA4 SLC27A4 | 2.88e-03 | 614 | 134 | 11 | GO:0140657 |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 3.04e-03 | 211 | 134 | 6 | GO:0016758 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA2D1 HTR1B CACNA2D2 SLC25A14 GRIK4 PKD1L2 SLC5A2 SLC6A9 SLC9C1 SLC18A1 SLC45A1 | 3.38e-03 | 627 | 134 | 11 | GO:0022890 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 3.63e-03 | 46 | 134 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | GABRG2 CACNA2D1 HTR1B CACNA2D2 GRIK4 PKD1L2 CHRM5 SLC9C1 PIEZO2 | 3.85e-03 | 459 | 134 | 9 | GO:0005216 |
| GeneOntologyMolecularFunction | phosphoric diester hydrolase activity | 4.15e-03 | 97 | 134 | 4 | GO:0008081 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA2D1 HTR1B CACNA2D2 GRIK4 PKD1L2 SLC5A2 SLC6A9 SLC9C1 SLC18A1 | 4.19e-03 | 465 | 134 | 9 | GO:0046873 |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 4.43e-03 | 15 | 134 | 2 | GO:0008559 | |
| GeneOntologyMolecularFunction | floppase activity | 5.04e-03 | 16 | 134 | 2 | GO:0140328 | |
| GeneOntologyMolecularFunction | immune receptor activity | 5.15e-03 | 165 | 134 | 5 | GO:0140375 | |
| GeneOntologyMolecularFunction | carbohydrate:monoatomic cation symporter activity | 5.69e-03 | 17 | 134 | 2 | GO:0005402 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 5.97e-03 | 171 | 134 | 5 | GO:0015081 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 6.27e-03 | 109 | 134 | 4 | GO:0042626 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 6.02e-12 | 61 | 133 | 10 | GO:0007187 | |
| GeneOntologyBiologicalProcess | G protein-coupled serotonin receptor signaling pathway | 8.89e-11 | 23 | 133 | 7 | GO:0098664 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | GABRG2 HTR1B HTR1D HTR1E HTR1F PSEN2 CACNA2D2 CNIH2 TSC2 GRIK4 LRRC4 CHRM2 CHRM5 CNIH3 LRP8 SLC6A9 ADRA1A GPR158 ATXN3 HRH2 SV2C FER1L5 CNR2 | 2.77e-08 | 931 | 133 | 23 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | GABRG2 HTR1B HTR1D HTR1E HTR1F PSEN2 CACNA2D2 CNIH2 TSC2 GRIK4 LRRC4 CHRM2 CHRM5 CNIH3 LRP8 SLC6A9 ADRA1A GPR158 ATXN3 HRH2 SV2C FER1L5 CNR2 | 2.77e-08 | 931 | 133 | 23 | GO:0007268 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | GABRG2 HTR1B HTR1D HTR1E HTR1F PSEN2 CACNA2D2 CNIH2 TSC2 GRIK4 LRRC4 CHRM2 CHRM5 CNIH3 LRP8 SLC6A9 ADRA1A GPR158 ATXN3 HRH2 SV2C FER1L5 CNR2 | 3.24e-08 | 939 | 133 | 23 | GO:0099537 |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting serotonin receptor signaling pathway | 5.70e-08 | 7 | 133 | 4 | GO:0007198 | |
| GeneOntologyBiologicalProcess | synaptic signaling | GABRG2 HTR1B HTR1D HTR1E HTR1F PSEN2 CACNA2D2 CNIH2 TSC2 GRIK4 LRRC4 CHRM2 CHRM5 CNIH3 LRP8 SLC6A9 ADRA1A GPR158 ATXN3 HRH2 SV2C FER1L5 CNR2 | 6.55e-08 | 976 | 133 | 23 | GO:0099536 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | GABRG2 ABCC3 XCR1 CACNA2D1 HTR1B ZMPSTE24 SPG7 PSEN2 CACNA2D2 WFS1 SLC25A14 GRIK4 ATP8B1 PKD1L2 ABCC6 SLC5A2 TG SLC6A9 SLC9C1 ADRA1A PIEZO2 SLC18A1 CLTC CCR1 CCR5 SLC38A11 SLC22A31 | 1.66e-07 | 1374 | 133 | 27 | GO:0006811 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | XCR1 HTR1B HTR1D GPR18 HTR1E HTR1F SPNS2 MRGPRE GPR84 OR2J3 GPR101 CHRM2 CHRM5 ADRA1A CXCR6 GPR158 OR51Q1 MRGPRG HRH2 CCR1 CCR5 GPRC5D TAS2R45 TAS2R43 TAS2R50 CNR2 ECE2 | 2.24e-07 | 1395 | 133 | 27 | GO:0007186 |
| GeneOntologyBiologicalProcess | glycoside transport | 2.60e-06 | 5 | 133 | 3 | GO:1901656 | |
| GeneOntologyBiologicalProcess | xenobiotic transmembrane transport | 5.94e-06 | 19 | 133 | 4 | GO:0006855 | |
| GeneOntologyBiologicalProcess | organic anion transport | CLN8 ABCC3 HTR1B ATP8B1 SLC44A4 ABCC6 PLIN2 ABCB4 SLC6A9 SLC22A14 HRH2 SLC38A11 SLC37A4 SLC27A4 | 6.21e-06 | 515 | 133 | 14 | GO:0015711 |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 1.98e-05 | 86 | 133 | 6 | GO:0007193 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | HTR1B HTR1D PSEN2 CACNA2D2 GRIK4 LRRC4 CHRM2 LRP8 SLC6A9 ADRA1A GPR158 HRH2 SV2C FER1L5 CNR2 | 2.51e-05 | 663 | 133 | 15 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | HTR1B HTR1D PSEN2 CACNA2D2 GRIK4 LRRC4 CHRM2 LRP8 SLC6A9 ADRA1A GPR158 HRH2 SV2C FER1L5 CNR2 | 2.55e-05 | 664 | 133 | 15 | GO:0099177 |
| GeneOntologyBiologicalProcess | xenobiotic transport | 5.81e-05 | 64 | 133 | 5 | GO:0042908 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | CLN8 ABCC3 HTR1B ATP8B1 ABCC6 PLIN2 ABCB4 SLC6A9 HRH2 SLC38A11 SLC27A4 | 7.21e-05 | 410 | 133 | 11 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | CLN8 ABCC3 HTR1B ATP8B1 ABCC6 PLIN2 ABCB4 SLC6A9 HRH2 SLC38A11 SLC27A4 | 7.53e-05 | 412 | 133 | 11 | GO:0015849 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | GABRG2 ABCC3 XCR1 CACNA2D1 SPG7 PSEN2 CACNA2D2 SLC25A14 GRIK4 ATP8B1 PKD1L2 ABCC6 SLC5A2 SLC6A9 SLC9C1 ADRA1A PIEZO2 SLC18A1 CCR5 | 9.84e-05 | 1115 | 133 | 19 | GO:0034220 |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 1.01e-04 | 286 | 133 | 9 | GO:0007188 | |
| GeneOntologyBiologicalProcess | co-translational protein modification | 1.23e-04 | 3 | 133 | 2 | GO:0043686 | |
| GeneOntologyBiologicalProcess | glucoside transport | 1.23e-04 | 3 | 133 | 2 | GO:0042946 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | XCR1 CACNA2D1 ZMPSTE24 SPG7 PSEN2 CACNA2D2 WFS1 SLC25A14 PKD1L2 SLC5A2 SLC6A9 SLC9C1 ADRA1A PIEZO2 SLC18A1 CLTC CCR1 CCR5 SLC38A11 | 1.59e-04 | 1157 | 133 | 19 | GO:0006812 |
| GeneOntologyBiologicalProcess | neurotransmitter transport | 2.82e-04 | 259 | 133 | 8 | GO:0006836 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter transport | 3.09e-04 | 141 | 133 | 6 | GO:0051588 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative transport | 3.95e-04 | 96 | 133 | 5 | GO:1901264 | |
| GeneOntologyBiologicalProcess | calcium ion transport | XCR1 CACNA2D1 ZMPSTE24 SPG7 PSEN2 CACNA2D2 WFS1 PKD1L2 ADRA1A CCR1 CCR5 | 4.67e-04 | 509 | 133 | 11 | GO:0006816 |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter receptor activity | 4.68e-04 | 56 | 133 | 4 | GO:0099601 | |
| GeneOntologyBiologicalProcess | acid secretion | 5.01e-04 | 57 | 133 | 4 | GO:0046717 | |
| GeneOntologyCellularComponent | dendrite | GABRG2 DHX36 BRINP3 HTR1B HTR1D HTR1E HTR1F WFS1 CNIH2 ARFGEF2 TSC2 GRIK4 LRRC4 CHRM2 CHRM5 CNIH3 LRP8 HRH2 RTN4RL2 CNR2 | 8.21e-07 | 858 | 137 | 20 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | GABRG2 DHX36 BRINP3 HTR1B HTR1D HTR1E HTR1F WFS1 CNIH2 ARFGEF2 TSC2 GRIK4 LRRC4 CHRM2 CHRM5 CNIH3 LRP8 HRH2 RTN4RL2 CNR2 | 8.51e-07 | 860 | 137 | 20 | GO:0097447 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | POMT2 CLN8 ZMPSTE24 PSEN2 WFS1 CNIH2 CERS6 CYP39A1 ABCC6 CNIH3 STT3A STT3B GDPD5 HSD3B7 RNF103 SLC18A1 ATXN3 PIGW ALG3 SELENOI ALDH3A2 SLC37A4 SLC27A4 PIGM RNF26 | 9.71e-07 | 1293 | 137 | 25 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | POMT2 CLN8 ZMPSTE24 PSEN2 WFS1 CNIH2 CERS6 CYP39A1 ABCC6 CNIH3 STT3A STT3B GDPD5 HSD3B7 RNF103 SLC18A1 ATXN3 PIGW ALG3 SELENOI ALDH3A2 SLC37A4 SLC27A4 PIGM RNF26 | 1.06e-06 | 1299 | 137 | 25 | GO:0098827 |
| GeneOntologyCellularComponent | synaptic membrane | GABRG2 CACNA2D1 HTR1B PSEN2 CACNA2D2 CNIH2 GRIK4 LRRC4 CHRM2 CHRM5 CNIH3 LRP8 SLC6A9 ADRA1A GPR158 CLTC | 1.43e-06 | 583 | 137 | 16 | GO:0097060 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | POMT2 CLN8 ZMPSTE24 PSEN2 WFS1 CNIH2 CERS6 CYP39A1 ABCC6 CNIH3 STT3A STT3B GDPD5 HSD3B7 RNF103 SLC18A1 ATXN3 PIGW ALG3 SELENOI ALDH3A2 SLC37A4 SLC27A4 PIGM RNF26 | 1.55e-06 | 1327 | 137 | 25 | GO:0042175 |
| GeneOntologyCellularComponent | somatodendritic compartment | GABRG2 DHX36 BRINP3 HTR1B HTR1D HTR1E HTR1F PSEN2 WFS1 CNIH2 ARFGEF2 TSC2 GRIK4 LRRC4 CHRM2 CHRM5 CNIH3 LRP8 GDPD5 HRH2 CCR1 RTN4RL2 CNR2 | 4.78e-06 | 1228 | 137 | 23 | GO:0036477 |
| GeneOntologyCellularComponent | presynaptic membrane | CACNA2D1 HTR1B PSEN2 CACNA2D2 GRIK4 CHRM2 SLC6A9 ADRA1A GPR158 CLTC | 1.48e-05 | 277 | 137 | 10 | GO:0042734 |
| GeneOntologyCellularComponent | postsynaptic membrane | GABRG2 CACNA2D1 CNIH2 GRIK4 LRRC4 CHRM2 CHRM5 CNIH3 LRP8 SLC6A9 ADRA1A GPR158 | 1.50e-05 | 405 | 137 | 12 | GO:0045211 |
| GeneOntologyCellularComponent | transport vesicle membrane | 1.38e-04 | 293 | 137 | 9 | GO:0030658 | |
| GeneOntologyCellularComponent | presynapse | CLN8 CACNA2D1 HTR1B PSEN2 CACNA2D2 WFS1 ARFGEF2 GRIK4 CHRM2 SLC6A9 ADRA1A GPR158 SLC18A1 CLTC SV2C FER1L5 | 2.31e-04 | 886 | 137 | 16 | GO:0098793 |
| GeneOntologyCellularComponent | glutamatergic synapse | GABRG2 CACNA2D1 HTR1D PSEN2 CNIH2 ARFGEF2 TSC2 GRIK4 LRRC4 CHRM2 CNIH3 LRP8 ADRA1A CLTC | 9.63e-04 | 817 | 137 | 14 | GO:0098978 |
| GeneOntologyCellularComponent | perichromatin fibrils | 1.16e-03 | 8 | 137 | 2 | GO:0005726 | |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 1.18e-03 | 179 | 137 | 6 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 1.18e-03 | 179 | 137 | 6 | GO:0030672 | |
| GeneOntologyCellularComponent | T-tubule | 1.81e-03 | 79 | 137 | 4 | GO:0030315 | |
| GeneOntologyCellularComponent | nuclear pore outer ring | 1.85e-03 | 10 | 137 | 2 | GO:0031080 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 2.13e-03 | 201 | 137 | 6 | GO:0099634 | |
| GeneOntologyCellularComponent | transport vesicle | 2.25e-03 | 519 | 137 | 10 | GO:0030133 | |
| GeneOntologyCellularComponent | motile cilium | 2.40e-03 | 355 | 137 | 8 | GO:0031514 | |
| GeneOntologyCellularComponent | postsynapse | GABRG2 CACNA2D1 CNIH2 ARFGEF2 TSC2 GRIK4 LRRC4 CHRM2 CHRM5 CNIH3 LRP8 SLC6A9 ADRA1A GPR158 CLTC | 2.80e-03 | 1018 | 137 | 15 | GO:0098794 |
| GeneOntologyCellularComponent | symmetric synapse | 3.17e-03 | 13 | 137 | 2 | GO:0032280 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 3.20e-03 | 45 | 137 | 3 | GO:0008328 | |
| GeneOntologyCellularComponent | synaptic vesicle | 3.68e-03 | 300 | 137 | 7 | GO:0008021 | |
| GeneOntologyCellularComponent | oligosaccharyltransferase complex | 3.68e-03 | 14 | 137 | 2 | GO:0008250 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 3.78e-03 | 157 | 137 | 5 | GO:0098839 | |
| Domain | GPCR_Rhodpsn_7TM | XCR1 HTR1B HTR1D GPR18 HTR1E HTR1F MRGPRE GPR84 OR2J3 GPR101 CHRM2 CHRM5 ADRA1A CXCR6 OR51Q1 MRGPRG HRH2 CCR1 CCR5 CNR2 | 6.55e-08 | 670 | 134 | 20 | IPR017452 |
| Domain | 7tm_1 | XCR1 HTR1B HTR1D GPR18 HTR1E HTR1F MRGPRE GPR84 OR2J3 GPR101 CHRM2 CHRM5 ADRA1A CXCR6 OR51Q1 MRGPRG HRH2 CCR1 CCR5 CNR2 | 7.76e-08 | 677 | 134 | 20 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | XCR1 HTR1B HTR1D GPR18 HTR1E HTR1F MRGPRE GPR84 OR2J3 GPR101 CHRM2 CHRM5 ADRA1A CXCR6 OR51Q1 MRGPRG HRH2 CCR1 CCR5 CNR2 | 9.38e-08 | 685 | 134 | 20 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | XCR1 HTR1B HTR1D GPR18 HTR1E HTR1F MRGPRE GPR84 OR2J3 GPR101 CHRM2 CHRM5 ADRA1A CXCR6 OR51Q1 MRGPRG HRH2 CCR1 CCR5 CNR2 | 1.08e-07 | 691 | 134 | 20 | PS50262 |
| Domain | GPCR_Rhodpsn | XCR1 HTR1B HTR1D GPR18 HTR1E HTR1F MRGPRE GPR84 OR2J3 GPR101 CHRM2 CHRM5 ADRA1A CXCR6 OR51Q1 MRGPRG HRH2 CCR1 CCR5 CNR2 | 1.11e-07 | 692 | 134 | 20 | IPR000276 |
| Domain | 7TM_GPCR_Srsx | 1.13e-07 | 112 | 134 | 9 | SM01381 | |
| Domain | 5HT_rcpt | 3.10e-07 | 9 | 134 | 4 | IPR002231 | |
| Domain | MFS_1 | 1.90e-05 | 77 | 134 | 6 | PF07690 | |
| Domain | MFS | 1.90e-05 | 77 | 134 | 6 | IPR011701 | |
| Domain | 5HT1F_rcpt | 5.11e-05 | 2 | 134 | 2 | IPR000450 | |
| Domain | STT3 | 5.11e-05 | 2 | 134 | 2 | PF02516 | |
| Domain | Oligo_trans_STT3 | 5.11e-05 | 2 | 134 | 2 | IPR003674 | |
| Domain | MFS | 1.28e-04 | 108 | 134 | 6 | PS50850 | |
| Domain | Cornichon_conserved | 1.53e-04 | 3 | 134 | 2 | IPR033466 | |
| Domain | CORNICHON | 1.53e-04 | 3 | 134 | 2 | PS01340 | |
| Domain | Chemokine_rcpt | 1.89e-04 | 16 | 134 | 3 | IPR000355 | |
| Domain | VGCC_alpha2 | 3.04e-04 | 4 | 134 | 2 | PF08473 | |
| Domain | VDCC_a2/dsu | 3.04e-04 | 4 | 134 | 2 | IPR013680 | |
| Domain | Multidrug-R_assoc | 3.04e-04 | 4 | 134 | 2 | IPR005292 | |
| Domain | Cornichon | 3.04e-04 | 4 | 134 | 2 | PF03311 | |
| Domain | Cornichon | 3.04e-04 | 4 | 134 | 2 | IPR003377 | |
| Domain | Cornichon | 3.04e-04 | 4 | 134 | 2 | SM01398 | |
| Domain | ABC_tran | 3.86e-04 | 48 | 134 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 3.86e-04 | 48 | 134 | 4 | PS50893 | |
| Domain | MFS_dom | 4.13e-04 | 134 | 134 | 6 | IPR020846 | |
| Domain | ABC_TRANSPORTER_1 | 4.18e-04 | 49 | 134 | 4 | PS00211 | |
| Domain | ABC_transporter-like | 4.52e-04 | 50 | 134 | 4 | IPR003439 | |
| Domain | VWA_N | 5.04e-04 | 5 | 134 | 2 | IPR013608 | |
| Domain | Musac_Ach_rcpt | 5.04e-04 | 5 | 134 | 2 | IPR000995 | |
| Domain | VWA_N | 5.04e-04 | 5 | 134 | 2 | PF08399 | |
| Domain | AAA+_ATPase | 6.05e-04 | 144 | 134 | 6 | IPR003593 | |
| Domain | AAA | 6.05e-04 | 144 | 134 | 6 | SM00382 | |
| Domain | ABC_membrane | 6.55e-04 | 24 | 134 | 3 | PF00664 | |
| Domain | TAS2R | 8.32e-04 | 26 | 134 | 3 | PF05296 | |
| Domain | T2R | 8.32e-04 | 26 | 134 | 3 | IPR007960 | |
| Domain | ABC_TM1F | 1.04e-03 | 28 | 134 | 3 | PS50929 | |
| Domain | ABC1_TM_dom | 1.04e-03 | 28 | 134 | 3 | IPR011527 | |
| Domain | MFS_sugar_transport-like | 2.17e-03 | 36 | 134 | 3 | IPR005828 | |
| Domain | Sugar_tr | 2.17e-03 | 36 | 134 | 3 | PF00083 | |
| Domain | MRGPCRFAMILY | 2.69e-03 | 11 | 134 | 2 | IPR026234 | |
| Domain | ABC_transporter_CS | 3.38e-03 | 42 | 134 | 3 | IPR017871 | |
| Domain | Carboxylesterase_B_CS | 3.78e-03 | 13 | 134 | 2 | IPR019819 | |
| Domain | CARBOXYLESTERASE_B_2 | 4.39e-03 | 14 | 134 | 2 | PS00941 | |
| Domain | COesterase | 4.39e-03 | 14 | 134 | 2 | PF00135 | |
| Domain | CarbesteraseB | 4.39e-03 | 14 | 134 | 2 | IPR002018 | |
| Domain | TLC | 5.74e-03 | 16 | 134 | 2 | PS50922 | |
| Domain | TLC | 5.74e-03 | 16 | 134 | 2 | SM00724 | |
| Domain | TRAM_LAG1_CLN8 | 5.74e-03 | 16 | 134 | 2 | PF03798 | |
| Domain | TLC-dom | 5.74e-03 | 16 | 134 | 2 | IPR006634 | |
| Domain | DUF1605 | 6.48e-03 | 17 | 134 | 2 | IPR011709 | |
| Domain | OB_NTP_bind | 6.48e-03 | 17 | 134 | 2 | PF07717 | |
| Pathway | WP_MONOAMINE_GPCRS | 1.35e-10 | 33 | 111 | 8 | M39585 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 1.08e-09 | 42 | 111 | 8 | M5868 | |
| Pathway | WP_MONOAMINE_GPCRS | 3.49e-09 | 31 | 111 | 7 | MM15871 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | XCR1 HTR1B HTR1D GPR18 HTR1E HTR1F OR2J3 CHRM2 CHRM5 ADRA1A HRH2 CCR1 CCR5 CNR2 | 1.59e-08 | 260 | 111 | 14 | M39397 |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 3.33e-08 | 42 | 111 | 7 | MM14971 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | XCR1 HTR1B HTR1D GPR18 HTR1E HTR1F CHRM2 CHRM5 ADRA1A CXCR6 HRH2 CCR1 CCR5 CNR2 ECE2 | 4.51e-08 | 330 | 111 | 15 | M18334 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | XCR1 HTR1B HTR1D GPR18 HTR1E HTR1F CHRM2 CHRM5 ADRA1A CXCR6 HRH2 CCR1 CCR5 TAS2R43 TAS2R50 CNR2 ECE2 | 1.19e-07 | 463 | 111 | 17 | M507 |
| Pathway | WP_GPCRS_NONODORANT | XCR1 HTR1B HTR1D GPR18 HTR1F CHRM2 CHRM5 ADRA1A CXCR6 HRH2 CCR1 GPRC5D CNR2 | 1.66e-07 | 266 | 111 | 13 | MM15843 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | XCR1 HTR1B HTR1D GPR18 HTR1F CHRM2 CHRM5 ADRA1A CXCR6 HRH2 CCR5 TAS2R45 TAS2R43 TAS2R50 CNR2 ECE2 | 2.44e-07 | 430 | 111 | 16 | MM15160 |
| Pathway | REACTOME_SEROTONIN_RECEPTORS | 1.72e-06 | 12 | 111 | 4 | M6034 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | XCR1 HTR1B HTR1D GPR18 HTR1F CHRM2 CHRM5 ADRA1A CXCR6 HRH2 CCR5 CNR2 ECE2 | 2.11e-06 | 333 | 111 | 13 | MM14963 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | XCR1 HTR1B HTR1D GPR18 HTR1F GPR84 CHRM2 CHRM5 ADRA1A CXCR6 HRH2 CCR1 CCR5 TAS2R45 TAS2R43 TAS2R50 CNR2 ECE2 | 2.75e-06 | 646 | 111 | 18 | MM14962 |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | HTR1B HTR1D GPR18 HTR1F CHRM2 CXCR6 CCR1 CCR5 TAS2R45 TAS2R43 TAS2R50 CNR2 | 2.84e-06 | 289 | 111 | 12 | MM15057 |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | HTR1B HTR1D GPR18 HTR1E HTR1F CHRM2 CXCR6 CCR1 CCR5 TAS2R43 TAS2R50 CNR2 | 6.64e-06 | 314 | 111 | 12 | M600 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | XCR1 HTR1B HTR1D GPR18 HTR1E HTR1F GPR84 CHRM2 CHRM5 ADRA1A CXCR6 HRH2 CCR1 CCR5 TAS2R43 TAS2R50 CNR2 ECE2 | 8.72e-06 | 702 | 111 | 18 | M746 |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | GABRG2 HTR1B HTR1D HTR1E HTR1F GRIK4 CHRM2 CHRM5 ADRA1A HRH2 CNR2 | 9.69e-06 | 272 | 111 | 11 | M13380 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.59e-05 | 186 | 111 | 9 | MM15994 | |
| Pathway | WP_GPCRS_ODORANT | 3.31e-05 | 157 | 111 | 8 | MM15872 | |
| Pathway | WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT | 7.43e-05 | 29 | 111 | 4 | M45551 | |
| Pathway | REACTOME_SEROTONIN_RECEPTORS | 7.49e-05 | 11 | 111 | 3 | MM15008 | |
| Pathway | WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY | 1.97e-04 | 37 | 111 | 4 | M42558 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 3.88e-04 | 44 | 111 | 4 | M11911 | |
| Pathway | WP_CHOLESTASIS | 4.20e-04 | 19 | 111 | 3 | M45520 | |
| Pathway | REACTOME_MUSCARINIC_ACETYLCHOLINE_RECEPTORS | 6.05e-04 | 5 | 111 | 2 | M27300 | |
| Pathway | REACTOME_MUSCARINIC_ACETYLCHOLINE_RECEPTORS | 6.05e-04 | 5 | 111 | 2 | MM15006 | |
| Pathway | WP_GPCRS_OTHER | 8.29e-04 | 93 | 111 | 5 | M39629 | |
| Pathway | BIOCARTA_MRP_PATHWAY | 9.03e-04 | 6 | 111 | 2 | M22078 | |
| Pathway | REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES | 1.04e-03 | 57 | 111 | 4 | M625 | |
| Pathway | REACTOME_DEX_H_BOX_HELICASES_ACTIVATE_TYPE_I_IFN_AND_INFLAMMATORY_CYTOKINES_PRODUCTION | 1.26e-03 | 7 | 111 | 2 | MM14930 | |
| Pathway | REACTOME_DEX_H_BOX_HELICASES_ACTIVATE_TYPE_I_IFN_AND_INFLAMMATORY_CYTOKINES_PRODUCTION | 1.26e-03 | 7 | 111 | 2 | M27227 | |
| Pubmed | HTR1B HTR1D HTR1E HTR1F CHRM2 CHRM5 ADRA1A CXCR6 HRH2 CCR1 CCR5 CNR2 | 3.03e-11 | 200 | 138 | 12 | 18240029 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | POMT2 COL4A4 DHX36 ABCC3 TCTN3 CACNA2D1 ZMPSTE24 WFS1 ARFGEF2 RNF213 TSC2 CERS6 PLA2G15 STT3A STT3B LRP8 TMTC3 EDEM2 ALG3 SELENOI ALDH3A2 SLC37A4 | 2.30e-09 | 1201 | 138 | 22 | 35696571 |
| Pubmed | 2.84e-09 | 179 | 138 | 10 | 18577758 | ||
| Pubmed | Suicide and serotonin: study of variation at seven serotonin receptor genes in suicide completers. | 8.23e-09 | 7 | 138 | 4 | 12627464 | |
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | 2.54e-08 | 118 | 138 | 8 | 19156168 | |
| Pubmed | GABRG2 HTR1B HTR1D HTR1E HTR1F TSC2 GRIK4 CHRM2 CHRM5 SLC6A9 ADRA1A | 3.57e-08 | 300 | 138 | 11 | 19086053 | |
| Pubmed | 6.11e-08 | 3 | 138 | 3 | 12110114 | ||
| Pubmed | Inflammation-induced hepatocellular carcinoma is dependent on CCR5 in mice. | 6.11e-08 | 3 | 138 | 3 | 23526353 | |
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 16824687 | ||
| Pubmed | DHX36 ABCC3 EFL1 XPO4 TSC2 WDR43 STT3B MST1 SLC6A9 HSD3B7 TLE1 CFAP20 ZNF408 CLTC EDEM2 ALG3 SELENOI STRA6 ALDH3A2 ZRANB1 | 3.11e-07 | 1327 | 138 | 20 | 32694731 | |
| Pubmed | Structural insights into the ligand binding and Gi coupling of serotonin receptor 5-HT5A. | 6.08e-07 | 5 | 138 | 3 | 35610220 | |
| Pubmed | Genotypes and haplotypes of CCR2 and CCR3 genes in Japanese cedar pollinosis. | 6.08e-07 | 5 | 138 | 3 | 17135764 | |
| Pubmed | Comparative human/murine sequence analysis of the common eliminated region 1 from human 3p21.3. | 6.95e-07 | 18 | 138 | 4 | 12461651 | |
| Pubmed | Association study of the serotoninergic system in migraine in the Spanish population. | 6.95e-07 | 18 | 138 | 4 | 19455600 | |
| Pubmed | 1.21e-06 | 6 | 138 | 3 | 10702689 | ||
| Pubmed | Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C. | 2.11e-06 | 7 | 138 | 3 | 20921899 | |
| Pubmed | ZMPSTE24 XPO4 STT3A STT3B DHX9 CSE1L TMTC3 CLTC NUP133 SMARCA4 ALDH3A2 NUP160 SLC27A4 | 2.36e-06 | 657 | 138 | 13 | 36180527 | |
| Pubmed | 3.37e-06 | 8 | 138 | 3 | 35550066 | ||
| Pubmed | 4.40e-06 | 164 | 138 | 7 | 32409323 | ||
| Pubmed | 5.05e-06 | 9 | 138 | 3 | 12070001 | ||
| Pubmed | 1.26e-05 | 75 | 138 | 5 | 2834384 | ||
| Pubmed | A common variant in DRD3 receptor is associated with autism spectrum disorder. | 1.28e-05 | 128 | 138 | 6 | 19058789 | |
| Pubmed | The human TAS2R16 receptor mediates bitter taste in response to beta-glucopyranosides. | 1.31e-05 | 12 | 138 | 3 | 12379855 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 17501853 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 1557407 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 33461297 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 25170871 | ||
| Pubmed | Primary structure and functional characterization of a human 5-HT1D-type serotonin receptor. | 1.56e-05 | 2 | 138 | 2 | 1652050 | |
| Pubmed | Molecular cloning of a serotonin receptor from human brain (5HT1E): a fifth 5HT1-like subtype. | 1.56e-05 | 2 | 138 | 2 | 1608964 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 14747380 | ||
| Pubmed | Mutations in STT3A and STT3B cause two congenital disorders of glycosylation. | 1.56e-05 | 2 | 138 | 2 | 23842455 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 31296534 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 28220208 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 25268648 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 20663902 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23217400 | ||
| Pubmed | MIP-3alpha and MIP-1alpha rapidly mobilize dendritic cell precursors into the peripheral blood. | 1.56e-05 | 2 | 138 | 2 | 18791167 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 22203055 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 29572910 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 1315531 | ||
| Pubmed | Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice. | 1.56e-05 | 2 | 138 | 2 | 14656931 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 20854195 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 22674804 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 21422162 | ||
| Pubmed | Age-dependent role for CCR5 in antiviral host defense against herpes simplex virus type 2. | 1.56e-05 | 2 | 138 | 2 | 16014944 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 15030585 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 17640964 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 21820390 | ||
| Pubmed | The middle X residue influences cotranslational N-glycosylation consensus site skipping. | 1.56e-05 | 2 | 138 | 2 | 25029371 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 36139350 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 1565658 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 17086356 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 7683036 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 12085329 | ||
| Pubmed | Role of Rho family GTPases in CCR1- and CCR5-induced actin reorganization in macrophages. | 1.56e-05 | 2 | 138 | 2 | 15882964 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 30181269 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 30591072 | ||
| Pubmed | Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection. | 1.56e-05 | 2 | 138 | 2 | 14757698 | |
| Pubmed | Localization-Specific Expression of CCR1 and CCR5 by Mast Cell Progenitors. | 1.56e-05 | 2 | 138 | 2 | 32174921 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 19603542 | ||
| Pubmed | SMARCA4 (BRG1) activates ABCC3 transcription to promote hepatocellular carcinogenesis. | 1.56e-05 | 2 | 138 | 2 | 38642845 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 18644849 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 16182378 | ||
| Pubmed | 1.70e-05 | 13 | 138 | 3 | 15938754 | ||
| Pubmed | ZMPSTE24 PSEN2 MED16 ARFGEF2 RNF213 CERS6 STT3A STT3B DHX9 LRP8 CSE1L CLTC NUP133 SMARCA4 SLC37A4 SLC27A4 | 1.70e-05 | 1168 | 138 | 16 | 19946888 | |
| Pubmed | 2.15e-05 | 14 | 138 | 3 | 36108118 | ||
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | CLN8 SPG7 WFS1 CERS6 CHRM2 CHRM5 TMEM62 ADRA1A CCR1 CCR5 SLC37A4 PIGM | 2.34e-05 | 697 | 138 | 12 | 28298427 |
| Pubmed | 3.13e-05 | 150 | 138 | 6 | 32423001 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 34942279 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 20696886 | ||
| Pubmed | Expression of serotonin receptors in mouse oocytes and preimplantation embryos. | 4.68e-05 | 3 | 138 | 2 | 12678665 | |
| Pubmed | STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion. | 4.68e-05 | 3 | 138 | 2 | 29765039 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 35894240 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 26472202 | ||
| Pubmed | Chemokine receptors Ccr1, Ccr2, and Ccr5 mediate neutrophil migration to postischemic tissue. | 4.68e-05 | 3 | 138 | 2 | 16275892 | |
| Pubmed | CCR2+ and CCR5+ CD8+ T cells increase during viral infection and migrate to sites of infection. | 4.68e-05 | 3 | 138 | 2 | 10940868 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 19553544 | ||
| Pubmed | Muscarinic cholinergic receptor (M2) plays a crucial role in the development of myopia in mice. | 4.68e-05 | 3 | 138 | 2 | 23649821 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 19167329 | ||
| Pubmed | Presynaptic α2δ subunits are key organizers of glutamatergic synapses. | 4.68e-05 | 3 | 138 | 2 | 33782113 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 29870711 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 11116158 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 17845218 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 25068656 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 15650194 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 20080692 | ||
| Pubmed | CC chemokine ligand 3 and receptors 1 and 5 gene expression in recurrent aphthous stomatitis. | 4.68e-05 | 3 | 138 | 2 | 22727097 | |
| Pubmed | Familial migraine with aura: association study with 5-HT1B/1D, 5-HT2C, and hSERT polymorphisms. | 4.68e-05 | 3 | 138 | 2 | 15109354 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 22425022 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 28733223 | ||
| Pubmed | DHPLC screening for mutations in progressive familial intrahepatic cholestasis patients. | 4.68e-05 | 3 | 138 | 2 | 20414253 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 16470129 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 33915153 | ||
| Pubmed | Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice. | 4.68e-05 | 3 | 138 | 2 | 17138939 | |
| Pubmed | Upregulation of cornichon transcripts in the dorsolateral prefrontal cortex in schizophrenia. | 4.68e-05 | 3 | 138 | 2 | 23103966 | |
| Pubmed | Follow-up examination of linkage and association to chromosome 1q43 in multiple sclerosis. | 6.63e-05 | 20 | 138 | 3 | 19626040 | |
| Pubmed | 7.71e-05 | 21 | 138 | 3 | 22842622 | ||
| Pubmed | 7.71e-05 | 21 | 138 | 3 | 10761934 | ||
| Pubmed | Evolutionary relationships of the Tas2r receptor gene families in mouse and human. | 8.91e-05 | 22 | 138 | 3 | 12734386 | |
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 18382674 | ||
| Interaction | CANX interactions | POMT2 GABRG2 ABCC3 TCTN3 CACNA2D1 ZMPSTE24 CACNA2D2 WFS1 NDST2 CERS6 DCT STT3A STT3B TG HSD3B7 TMTC3 CLTC EDEM2 ATXN3 NUP133 SELENOI ALDH3A2 ZRANB1 NUP160 CNR2 RNF26 | 8.08e-08 | 1261 | 128 | 26 | int:CANX |
| Interaction | CCL4 interactions | 1.68e-06 | 32 | 128 | 5 | int:CCL4 | |
| Interaction | UNC93B1 interactions | TCTN3 HTR1B XPO4 RNF213 GPR101 STT3A STT3B CSE1L NUP133 GPRC5D TM4SF18 ALDH3A2 SLC27A4 | 2.60e-06 | 417 | 128 | 13 | int:UNC93B1 |
| Interaction | CRELD1 interactions | 9.69e-06 | 163 | 128 | 8 | int:CRELD1 | |
| Cytoband | 3p21.3 | 3.04e-05 | 59 | 137 | 4 | 3p21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p21 | 4.91e-05 | 316 | 137 | 7 | chr3p21 | |
| Cytoband | 3p21 | 1.33e-04 | 33 | 137 | 3 | 3p21 | |
| Cytoband | 13q32 | 6.75e-04 | 13 | 137 | 2 | 13q32 | |
| Cytoband | 2q24.3 | 1.03e-03 | 16 | 137 | 2 | 2q24.3 | |
| GeneFamily | Solute carriers | SLC25A14 SLC44A4 SLC5A2 SLC6A9 SLC9C1 SLC25A43 SLC50A1 SLC18A1 SLC22A14 SLC35G3 SLC38A11 SLC45A1 SLC37A4 SLC27A4 SLC22A31 | 8.81e-09 | 395 | 105 | 15 | 752 |
| GeneFamily | 5-hydroxytryptamine receptors, G protein-coupled | 7.38e-07 | 13 | 105 | 4 | 170 | |
| GeneFamily | Dolichyl D-mannosyl phosphate dependent mannosyltransferases|Phosphatidylinositol glycan anchor biosynthesis | 1.56e-05 | 9 | 105 | 3 | 430 | |
| GeneFamily | STT3 oligosaccharyltransferase catalytic subunits|Oligosaccharyltransferase complex subunits | 3.34e-05 | 2 | 105 | 2 | 444 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 9.05e-05 | 78 | 105 | 5 | 262 | |
| GeneFamily | Cholinergic receptors muscarinic | 3.30e-04 | 5 | 105 | 2 | 180 | |
| GeneFamily | Exportins | 6.88e-04 | 7 | 105 | 2 | 547 | |
| GeneFamily | G protein-coupled receptors, Class C orphans | 6.88e-04 | 7 | 105 | 2 | 285 | |
| GeneFamily | CD molecules|C-C motif chemokine receptors | 1.46e-03 | 10 | 105 | 2 | 1091 | |
| GeneFamily | Taste 2 receptors | 1.49e-03 | 39 | 105 | 3 | 1162 | |
| GeneFamily | Oligosaccharyltransferase complex subunits | 2.12e-03 | 12 | 105 | 2 | 445 | |
| GeneFamily | ATP binding cassette subfamily C | 2.50e-03 | 13 | 105 | 2 | 807 | |
| GeneFamily | DEAH-box helicases | 3.80e-03 | 16 | 105 | 2 | 500 | |
| GeneFamily | Glycosyl transferases group 1 domain containing|Phosphatidylinositol glycan anchor biosynthesis | 6.53e-03 | 21 | 105 | 2 | 680 | |
| GeneFamily | Calcium voltage-gated channel subunits | 9.91e-03 | 26 | 105 | 2 | 253 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.77e-07 | 164 | 137 | 7 | c5bfae7e9497185548c243d6f9ebadbcef48ba7f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.77e-07 | 164 | 137 | 7 | 76b0ac220b7ca22fbea28a507f01f96ae9f53932 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.77e-07 | 164 | 137 | 7 | 911081739174ec68bc0893c804e4276b206bea7d | |
| ToppCell | droplet-Tongue-nan-24m-Myeloid-basal_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-06 | 178 | 137 | 7 | 9423e209de94d26e96117581c95dc069850225d3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.00e-06 | 189 | 137 | 7 | c3df0e3c50af8f1cfb4d790e668bd7f42b276992 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Dendritic_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.64e-06 | 197 | 137 | 7 | e0fc098bfb5a8b7824ae339f3adda30f78360d0b | |
| ToppCell | severe-Plasmablast|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.73e-06 | 198 | 137 | 7 | 0b1620ad4352ee5d599a72931aaceab4ca407498 | |
| ToppCell | remission-unassigned|World / disease stage, cell group and cell class | 8.60e-06 | 155 | 137 | 6 | d81bec894381e3e2d6249a567e8108b8423e5c54 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.94e-06 | 159 | 137 | 6 | c0e55f25271f788c08fa4b95186501fc27b2ec39 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.61e-05 | 173 | 137 | 6 | b9dee61973559e8c2fef3f2dafd43475b386befb | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-05 | 176 | 137 | 6 | adb679e69c0c17f0caee4c141bac55d03c963012 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.77e-05 | 176 | 137 | 6 | 437cfc5e06416bb0fc76d1f9dc106f74e279e880 | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 183 | 137 | 6 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | CF-Lymphoid-B_cell|CF / Disease state, Lineage and Cell class | 2.72e-05 | 190 | 137 | 6 | 374d8fd63c733178acab07682ed1519693efab45 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.72e-05 | 190 | 137 | 6 | 84eb7761f537d270673909a71d4f122e826769d5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.80e-05 | 191 | 137 | 6 | fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b | |
| ToppCell | Severe_COVID-19-Epithelial-transitional_Epi|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.33e-05 | 197 | 137 | 6 | 5ad3cd4c77016e862041baac3076f8cc0f75c417 | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-T/NK-NK_CD56bright|ICU-SEP / Disease, condition lineage and cell class | 3.33e-05 | 197 | 137 | 6 | c187e3fc2160b0165eb039cf09a6e621016068b7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.33e-05 | 197 | 137 | 6 | b8dc192fc98428bbb701cc2ea57fc8ad93397785 | |
| ToppCell | control-B_intermediate|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.43e-05 | 198 | 137 | 6 | e24345c8cec8c21f7b5163b7326ba8f83a587ce3 | |
| ToppCell | severe-Plasmablast|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.53e-05 | 199 | 137 | 6 | 6ee4c2e6049860071169366b7e662d5c1a3cc54b | |
| ToppCell | distal-Hematologic-Myeloid_Dendritic_Type_1-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.53e-05 | 199 | 137 | 6 | 78e70852acda95d2c770cdd539a46b291f929a78 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.63e-05 | 200 | 137 | 6 | d0167f96314be78b6d867bbcc6e4396071d931b8 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-dn_T|Int-URO / Disease, condition lineage and cell class | 3.63e-05 | 200 | 137 | 6 | 020439d9e70fff7246650ab0e9105236688c3ec3 | |
| ToppCell | mild-B_intermediate|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.63e-05 | 200 | 137 | 6 | 8e3132a1fe3708f725c5c4077878fb87bbea3678 | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Granulocytic_cells-Mast-cells|LPS_only / Treatment groups by lineage, cell group, cell type | 3.63e-05 | 200 | 137 | 6 | afbbfe0b8e66df36c244935182cb26feeb31a085 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Fibcd1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.13e-05 | 130 | 137 | 5 | c70fb77324916d220d842a575558a8245c276599 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Nxph3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.82e-05 | 138 | 137 | 5 | b63e26afafbd2cdeed9c9451e6f530ab6295504c | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.34e-05 | 144 | 137 | 5 | e2a2f260f5ebaaef46248d199c407a15ce9d024a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.61e-05 | 145 | 137 | 5 | 8da10bc6611976e1ec85e09f04a2dc5bf6555c9e | |
| ToppCell | E16.5-samps-Myeloid-Macrophage|E16.5-samps / Age Group, Lineage, Cell class and subclass | 9.48e-05 | 148 | 137 | 5 | cd5f697d8c2f272be1f3f52a05446749278431c5 | |
| ToppCell | E16.5-samps-Myeloid-Macrophage-CD163+_Macrophage|E16.5-samps / Age Group, Lineage, Cell class and subclass | 9.48e-05 | 148 | 137 | 5 | 56e146980a71b5ca655118ae13310c5949220d4a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 151 | 137 | 5 | 16fc903fc71e25717b9908416f0bcd29c0a65a61 | |
| ToppCell | remission-unassigned|remission / disease stage, cell group and cell class | 1.14e-04 | 154 | 137 | 5 | 4130769829b838cc8a075c87ff6c187f0f507f8b | |
| ToppCell | 368C-Fibroblasts-Fibroblast-H|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-04 | 154 | 137 | 5 | f29316d4b4dcdb23bd427d78068e65a9802f7f07 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-H-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-04 | 154 | 137 | 5 | 66065c0763c83d98084ca6969694c3af37e43274 | |
| ToppCell | Striatum-Hematopoietic|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.18e-04 | 155 | 137 | 5 | 12301d823338bf829475905c66c5f08f7159d29f | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Hsd11b1_Endou|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.29e-04 | 158 | 137 | 5 | c8af8964a140acb2987e3b4906d72c546108d229 | |
| ToppCell | Frontal_cortex-Hematopoietic-MICROGLIA|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.33e-04 | 159 | 137 | 5 | 41d2c1e71f6983156f8cc8ec5f69e025e5700f46 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-04 | 160 | 137 | 5 | c42bcc6c7d113f0db43febb088b75ca4ac7cb7a3 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.45e-04 | 162 | 137 | 5 | 478cf560ef33c5c324142c76417447d4a571a2c9 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.49e-04 | 163 | 137 | 5 | 1e8ab00ecc2d2ba35aa6745c0ed38663e26312e8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.49e-04 | 163 | 137 | 5 | 431221a41d396b09170476179590eaf8a55266d8 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.53e-04 | 164 | 137 | 5 | d8ecb3de6e34f5f574449e3d2f26fa0b2b7e84e8 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 166 | 137 | 5 | 548d0d6c0ffd564036ddba78620734220ebb73d7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 166 | 137 | 5 | 80e164a89d22098cabe4a99a78283ba69ea0561e | |
| ToppCell | moderate-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.62e-04 | 166 | 137 | 5 | c3835b424c63bf11a4e2c47635dc3787fc4a637a | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6-Excitatory_Neuron.Slc17a7.Bcl6-Ndst4_(Subiculum)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.64e-04 | 89 | 137 | 4 | 497771687b48c7e0fa87e31962feaafd8f248b98 | |
| ToppCell | facs-Marrow-B-cells-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-04 | 168 | 137 | 5 | 08fe8fa43c343c03f9a2f0b982192fde04a7c027 | |
| ToppCell | facs-Marrow-B-cells-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-04 | 168 | 137 | 5 | d4053b2fffb19e0376b8ceb92e87ec4447d96a3e | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Spindle_Cell-1|TCGA-Uvea / Sample_Type by Project: Shred V9 | 1.72e-04 | 168 | 137 | 5 | b427746929bb40e3d1b5f1c40d302b792d6b32a5 | |
| ToppCell | 390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.76e-04 | 169 | 137 | 5 | 2c851b2703c7b8b656026f996f5fc027e4a79b36 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_CMAHP|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.81e-04 | 170 | 137 | 5 | 49fc45d8a5c3ad89d1649fa46d7a285891379392 | |
| ToppCell | (7)_MNP-(7)_DC_activated|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.81e-04 | 170 | 137 | 5 | 4ab495b38a071fa8207331df2ce0d78a2dcd034e | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.86e-04 | 171 | 137 | 5 | 3ef44a5e3e8f81424f1e9aa302860b6688a549b8 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.86e-04 | 171 | 137 | 5 | 3a2fefcb62e9d47ae6b3a946c45d3f2dd32c576c | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.86e-04 | 171 | 137 | 5 | 285533ca2a6a411773313166bee35542f34d1a3c | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.92e-04 | 172 | 137 | 5 | c8ea80042faf923b08ff03d73100533d521d73ef | |
| ToppCell | mild_COVID-19_(asymptomatic)-cDC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.97e-04 | 173 | 137 | 5 | 71dc0051c87b84e3cf13cde8858166f2a474b5dc | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Mesenchymal_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.97e-04 | 173 | 137 | 5 | b43817a6b1ed8d6b5366702343be4311c0d52d83 | |
| ToppCell | 390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-04 | 173 | 137 | 5 | 1f725ff16e28636b20ef26f3fa9be8b47c89378d | |
| ToppCell | Endothelial-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.97e-04 | 173 | 137 | 5 | a81992965137195d20fc498f750975303961a828 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-04 | 174 | 137 | 5 | 110369f6b78de34a6d934b5b47cecd023347bc80 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.02e-04 | 174 | 137 | 5 | a62531ebf16b32b249168dca11b870f63a8aa81c | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 175 | 137 | 5 | 3f1b2e23fec953148fb0711e523c463adb07dca4 | |
| ToppCell | AT1-AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 2.08e-04 | 175 | 137 | 5 | bdd85ba280648a0283c1984662a34c7b840f64dd | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.08e-04 | 175 | 137 | 5 | 3b5346fba617292de71963b6175e85a4f182fe30 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.08e-04 | 175 | 137 | 5 | ff0789f5913c9f3c49159e40b1ec3d2ff175ec9f | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.08e-04 | 175 | 137 | 5 | 53e6f1f8dd482dfa2539e068dacefbb6e08443bc | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Hematologic-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 175 | 137 | 5 | ca2eabf03b70353e7eb15b6f622b2f9223a99e18 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.08e-04 | 175 | 137 | 5 | 21f8f11a8b874d4f7c47931010a2535f2a5a3373 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.13e-04 | 176 | 137 | 5 | 2e1003dc373b14d27f0464d980453fdcfc1005f0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_THTPA|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.13e-04 | 176 | 137 | 5 | e788c7e0b2bfde31fddbf9e04d07140f8b964857 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.19e-04 | 177 | 137 | 5 | ab92ffc9624850a50c88e6b8f3a517ff2251ff15 | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-04 | 177 | 137 | 5 | 35d42b07d9c31528bf59199e361bb8a3bfbe3b75 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-B_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.19e-04 | 177 | 137 | 5 | d4db058c09012ec9fbde61277a9f86d9956de8fc | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_1-Pericyte|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.19e-04 | 177 | 137 | 5 | 68263456a3c93cd195b321b309ff59e156d732fe | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-B_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.19e-04 | 177 | 137 | 5 | 320fd77c7c98e9305dcc34a168ec9d674539ed65 | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.19e-04 | 177 | 137 | 5 | e415e448c37adc102d766235e9953dec32c021f1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.25e-04 | 178 | 137 | 5 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-04 | 178 | 137 | 5 | 7467e5ab2fcb39cc4a2c7dd69722c91def3b6aea | |
| ToppCell | normal-na-Lymphocytic_B-plasmablast-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.25e-04 | 178 | 137 | 5 | 40a280c1e35963dd45d1809a3e85b568344dd1f5 | |
| ToppCell | normal-na-Lymphocytic_B-plasmablast|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.25e-04 | 178 | 137 | 5 | 4fe87c713770173336177e3488f7b4a3be54f71b | |
| ToppCell | Posterior_cortex-Hematopoietic|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.25e-04 | 178 | 137 | 5 | ea9e4f461dda34c0ebc707d7dbefc7a49ce5bb55 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-04 | 178 | 137 | 5 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.30e-04 | 179 | 137 | 5 | 8ce5000088b727783a0619baa16a2cd036d21f54 | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell-B_cell-B_activate-7|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.36e-04 | 180 | 137 | 5 | 9f4bbaf6435c23e3e552ae22be8ea7884314192d | |
| ToppCell | cellseq-Immune-Lymphocytic_B-Lymphocytic_B|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.36e-04 | 180 | 137 | 5 | cd04d7bf92986a5b8a0193c9b92ec47da3929bac | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 180 | 137 | 5 | d76349ecef7c5878bf215e946f032264161eb61b | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell-B_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.36e-04 | 180 | 137 | 5 | b465f2f8b0e9a2034a4f1272bb00c77439164dbf | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.36e-04 | 180 | 137 | 5 | cc31d2cd06161300b91b17a67bb432b75f0d719b | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.36e-04 | 180 | 137 | 5 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.36e-04 | 180 | 137 | 5 | c3c72531af5b9f7a7416727fe609dab5180e03b6 | |
| ToppCell | cellseq-Immune-Lymphocytic_B|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.36e-04 | 180 | 137 | 5 | 663a800ab70e7ab7d13183417f9c1ed36907aa5e | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.36e-04 | 180 | 137 | 5 | a600bc705993d3a010550a25d3b54358946f061f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_GGT8P|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.43e-04 | 181 | 137 | 5 | 9842537f9a607d8557c43790008d175edab1f32c | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.43e-04 | 181 | 137 | 5 | 9de2f2cc5f02e0ca599c9e0d2cb1e1e4b5aac112 | |
| ToppCell | Endothelial-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.43e-04 | 181 | 137 | 5 | 4fe0215d08f03d4e24749d70fce01b7aa22906fd | |
| ToppCell | T_cells-Resident_memory_CD8+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 2.49e-04 | 182 | 137 | 5 | 111d434b89902ec11fb07f41b8ee1a98f3991b61 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.49e-04 | 182 | 137 | 5 | 94d061b7b5ebbfc564c644bc8b2d52341927145d | |
| Computational | Genes in the cancer module 571. | 1.63e-04 | 15 | 79 | 3 | MODULE_571 | |
| Computational | Neighborhood of MAGEA9 | COL4A4 CACNA2D1 BRINP3 HTR1B GPR18 HTR1E ARFGEF2 ATP8B1 ADRA1A SLC18A1 ATXN3 | 2.49e-04 | 423 | 79 | 11 | MORF_MAGEA9 |
| Computational | Neighborhood of IL16 | 3.56e-04 | 239 | 79 | 8 | MORF_IL16 | |
| Computational | Neighborhood of RAD51L3 | CACNA2D1 BRINP3 HTR1B GPR18 HTR1E ARFGEF2 ATP8B1 ADRA1A SLC18A1 ATXN3 | 5.11e-04 | 387 | 79 | 10 | MORF_RAD51L3 |
| Computational | Neighborhood of ATF2 | CACNA2D1 BRINP3 GPR18 HTR1E ARFGEF2 ATP8B1 ADRA1A TLE1 ATXN3 | 6.75e-04 | 330 | 79 | 9 | MORF_ATF2 |
| Drug | thioridazine | 1.14e-09 | 79 | 137 | 9 | CID000005452 | |
| Drug | alpha-methylserotonin | 2.93e-09 | 22 | 137 | 6 | CID000115292 | |
| Drug | NSC95090 | 3.87e-09 | 40 | 137 | 7 | CID000003251 | |
| Drug | Olanzapine | 6.85e-09 | 25 | 137 | 6 | DB00334 | |
| Drug | Ziprasidone | 6.85e-09 | 25 | 137 | 6 | DB00246 | |
| Drug | Aripiprazole | 6.85e-09 | 25 | 137 | 6 | DB01238 | |
| Drug | Clozapine | 8.87e-09 | 26 | 137 | 6 | DB00363 | |
| Drug | Quetiapine | 8.87e-09 | 26 | 137 | 6 | DB01224 | |
| Drug | NSC196867 | 9.08e-09 | 13 | 137 | 5 | CID000003982 | |
| Drug | loxapine | 1.08e-08 | 46 | 137 | 7 | CID000003964 | |
| Drug | zotepine | 1.70e-08 | 49 | 137 | 7 | CID000005736 | |
| Drug | 3-isoreserpine | ABCC3 CACNA2D1 HTR1B HTR1D HTR1F ABCA13 CHRM2 ABCC6 ABCB4 ADRA1A SLC18A1 | 2.17e-08 | 190 | 137 | 11 | CID000005052 |
| Drug | xanomeline | 2.77e-08 | 31 | 137 | 6 | CID000060809 | |
| Drug | mesoridazine | 4.12e-08 | 33 | 137 | 6 | CID000004078 | |
| Drug | Eletriptan | 4.33e-08 | 7 | 137 | 4 | DB00216 | |
| Drug | BRL 34778 | 4.33e-08 | 7 | 137 | 4 | CID000135770 | |
| Drug | quetiapine | 5.04e-08 | 57 | 137 | 7 | CID000005002 | |
| Drug | norfenfluramine | 8.48e-08 | 37 | 137 | 6 | CID000015897 | |
| Drug | secoverine | 8.62e-08 | 8 | 137 | 4 | CID000042470 | |
| Drug | fluphenazine | 1.01e-07 | 94 | 137 | 8 | CID000003372 | |
| Drug | Saphris | 1.61e-07 | 41 | 137 | 6 | CID000163091 | |
| Drug | amitriptyline | 1.78e-07 | 140 | 137 | 9 | CID000002160 | |
| Drug | Rizatriptan | 2.13e-07 | 3 | 137 | 3 | DB00953 | |
| Drug | AC1Q5UBL | GABRG2 CACNA2D1 HTR1B HTR1F GRIK4 CHRM2 STT3A ADRA1A SLC18A1 | 2.55e-07 | 146 | 137 | 9 | CID000005466 |
| Drug | CM 29-712 | 2.56e-07 | 10 | 137 | 4 | CID000159842 | |
| Drug | LY344864 | 2.56e-07 | 10 | 137 | 4 | CID005311097 | |
| Drug | spiperone | 2.97e-07 | 108 | 137 | 8 | CID000005265 | |
| Drug | chlorpromazine | CACNA2D1 HTR1B HTR1D HTR1E HTR1F CHRM2 CHRM5 ADRA1A ZMYND10 CLTC | 3.31e-07 | 197 | 137 | 10 | CID000002726 |
| Drug | pizotifen | 3.54e-07 | 25 | 137 | 5 | CID000027400 | |
| Drug | cyclandelate | 4.01e-07 | 11 | 137 | 4 | CID000002893 | |
| Drug | dicyclomine | 4.01e-07 | 11 | 137 | 4 | CID000003042 | |
| Drug | alniditan | 4.01e-07 | 11 | 137 | 4 | CID000066004 | |
| Drug | Ergot | 4.24e-07 | 48 | 137 | 6 | CID000003250 | |
| Drug | 1-(1-naphthyl)piperazine | 4.36e-07 | 26 | 137 | 5 | CID000001342 | |
| Drug | T15550 | 4.36e-07 | 26 | 137 | 5 | CID000005454 | |
| Drug | sertindole | 5.44e-07 | 50 | 137 | 6 | CID000060149 | |
| Drug | AQ-RA 741 | 5.98e-07 | 12 | 137 | 4 | CID000129989 | |
| Drug | citalopram | 6.67e-07 | 120 | 137 | 8 | CID000002771 | |
| Drug | Zolmitriptan | 8.49e-07 | 4 | 137 | 3 | DB00315 | |
| Drug | Is 159 | 8.49e-07 | 4 | 137 | 3 | CID000196859 | |
| Drug | Naratriptan | 8.49e-07 | 4 | 137 | 3 | DB00952 | |
| Drug | Sumatriptan | 8.49e-07 | 4 | 137 | 3 | DB00669 | |
| Drug | MDL 72832 | 8.60e-07 | 13 | 137 | 4 | CID000182585 | |
| Drug | AC1L1G8Z | 9.26e-07 | 30 | 137 | 5 | CID000003581 | |
| Drug | mianserin | 9.58e-07 | 87 | 137 | 7 | CID000004184 | |
| Drug | idazoxan | 1.12e-06 | 89 | 137 | 7 | CID000054459 | |
| Drug | L-694,247 | 1.20e-06 | 14 | 137 | 4 | CID000132059 | |
| Drug | Nicardipine | 1.20e-06 | 14 | 137 | 4 | DB00622 | |
| Drug | ketanserin | 1.30e-06 | 131 | 137 | 8 | CID000003822 | |
| Drug | dotarizine | 1.63e-06 | 15 | 137 | 4 | CID000055285 | |
| Drug | urapidil | 1.77e-06 | 34 | 137 | 5 | CID000005639 | |
| Drug | Trelibet | 2.11e-06 | 5 | 137 | 3 | CID000065975 | |
| Drug | GR 127935 | 2.11e-06 | 5 | 137 | 3 | ctd:C090701 | |
| Drug | BEA 1654 | 2.11e-06 | 5 | 137 | 3 | CID000125354 | |
| Drug | 4-amino-5-chloro-2-methoxybenzamide | 2.11e-06 | 5 | 137 | 3 | CID009834239 | |
| Drug | I 370 | 2.11e-06 | 5 | 137 | 3 | CID000089576 | |
| Drug | centbutindole | 2.11e-06 | 5 | 137 | 3 | CID000068663 | |
| Drug | Methysergide | 2.11e-06 | 5 | 137 | 3 | ctd:D008784 | |
| Drug | CP-132,484 | 2.11e-06 | 5 | 137 | 3 | CID000132564 | |
| Drug | AC1LCKBJ | 2.11e-06 | 5 | 137 | 3 | CID000601768 | |
| Drug | desipramine | 2.13e-06 | 188 | 137 | 9 | CID000002995 | |
| Drug | L-DOPA methyl ester | 2.16e-06 | 16 | 137 | 4 | CID000023497 | |
| Drug | S-(-)-Lisuride | 2.62e-06 | 65 | 137 | 6 | CID000003938 | |
| Drug | promazine | 2.74e-06 | 37 | 137 | 5 | CID000004926 | |
| Drug | TFMPP | 2.74e-06 | 37 | 137 | 5 | CID000004296 | |
| Drug | benzoctamine | 3.60e-06 | 18 | 137 | 4 | CID000028425 | |
| Drug | tripitramine | 3.60e-06 | 18 | 137 | 4 | CID000132947 | |
| Drug | AC1NUW4G | 4.07e-06 | 40 | 137 | 5 | CID005462134 | |
| Drug | pyrrolo(1,2-a)quinoxaline | 4.21e-06 | 6 | 137 | 3 | CID000067476 | |
| Drug | R 28935 | 4.21e-06 | 6 | 137 | 3 | CID000093307 | |
| Drug | oriens | 4.37e-06 | 154 | 137 | 8 | CID000161645 | |
| Drug | EEDQ | 4.80e-06 | 72 | 137 | 6 | CID000027833 | |
| Drug | haloperidol | GABRG2 HTR1B HTR1D HTR1E HTR1F GRIK4 CHRM2 CHRM5 ADRA1A ZMYND10 SLC18A1 CNR2 | 4.86e-06 | 394 | 137 | 12 | CID000003559 |
| Drug | nisoxetine | 5.21e-06 | 42 | 137 | 5 | CID000004500 | |
| Drug | Doxepin | 5.64e-06 | 20 | 137 | 4 | DB01142 | |
| Drug | 6-nitroquipazine | 5.64e-06 | 20 | 137 | 4 | CID000005012 | |
| Drug | gamma-aminobutyric acid | GABRG2 CACNA2D1 HTR1B HTR1D SPG7 CACNA2D2 GRIK4 CHRM2 SLC6A9 ZMYND10 SLC18A1 ALDH3A2 CNR2 | 6.01e-06 | 474 | 137 | 13 | CID000000119 |
| Drug | SCH 23390 | 6.62e-06 | 116 | 137 | 7 | CID000005018 | |
| Drug | epicholesterol | HTR1B HTR1D HTR1E HTR1F ZMPSTE24 ATP8B1 CYP39A1 CHRM2 PLA2G15 PLIN2 LRP8 ABCB4 HSD3B7 CLTC SLC27A4 | 6.98e-06 | 636 | 137 | 15 | CID000000304 |
| Drug | methiothepin | 7.10e-06 | 77 | 137 | 6 | CID000004106 | |
| Drug | NSC755875 | 7.26e-06 | 165 | 137 | 8 | CID000002215 | |
| Drug | adafenoxate | 7.33e-06 | 7 | 137 | 3 | CID000064517 | |
| Drug | LY334370 | 7.33e-06 | 7 | 137 | 3 | CID005311258 | |
| Drug | L-689,660 | 7.33e-06 | 7 | 137 | 3 | CID000132658 | |
| Drug | NSC186061 | 7.41e-06 | 118 | 137 | 7 | CID000004163 | |
| Drug | promethazine | 8.24e-06 | 46 | 137 | 5 | CID000004927 | |
| Drug | oxymetazoline | 8.24e-06 | 79 | 137 | 6 | CID000004636 | |
| Drug | zacopride | 8.44e-06 | 22 | 137 | 4 | CID000108182 | |
| Drug | mCPBG | 8.44e-06 | 22 | 137 | 4 | CID000001354 | |
| Drug | GR127935 | 8.44e-06 | 22 | 137 | 4 | CID000107780 | |
| Drug | buspirone | 8.87e-06 | 80 | 137 | 6 | CID000002477 | |
| Drug | clomipramine | 8.87e-06 | 80 | 137 | 6 | CID000002801 | |
| Drug | fluoxetine | 9.18e-06 | 225 | 137 | 9 | CID000003386 | |
| Drug | aganodine | 1.02e-05 | 23 | 137 | 4 | CID000176878 | |
| Drug | AC1NDOB4 | 1.02e-05 | 23 | 137 | 4 | CID004629010 | |
| Drug | One-time | 1.02e-05 | 48 | 137 | 5 | CID000040813 | |
| Drug | Neomigran | 1.02e-05 | 48 | 137 | 5 | CID000003066 | |
| Drug | WAY-100635 | 1.13e-05 | 49 | 137 | 5 | CID000005684 | |
| Drug | AC1L5AAF | 1.17e-05 | 8 | 137 | 3 | CID000173615 | |
| Drug | medifoxamine | 1.17e-05 | 8 | 137 | 3 | CID000036109 | |
| Disease | intrahepatic cholestasis (is_implicated_in) | 3.57e-07 | 4 | 133 | 3 | DOID:1852 (is_implicated_in) | |
| Disease | generalized anxiety disorder (implicated_via_orthology) | 4.93e-06 | 8 | 133 | 3 | DOID:14320 (implicated_via_orthology) | |
| Disease | Depressive disorder | 6.90e-06 | 289 | 133 | 9 | C0011581 | |
| Disease | Schizophrenia | GABRG2 HTR1F PSEN2 ABCA13 GRIK4 CHRM2 CHRM5 CNIH3 LRP8 SLC6A9 ADRA1A SLC18A1 EDEM2 CCR5 CNR2 | 1.12e-05 | 883 | 133 | 15 | C0036341 |
| Disease | congenital disorder of glycosylation Iw (implicated_via_orthology) | 2.02e-05 | 2 | 133 | 2 | DOID:0080572 (implicated_via_orthology) | |
| Disease | Progressive intrahepatic cholestasis (disorder) | 6.03e-05 | 3 | 133 | 2 | C0268312 | |
| Disease | Progressive familial intrahepatic cholestasis type 3 | 6.03e-05 | 3 | 133 | 2 | cv:C1865643 | |
| Disease | restrictive dermopathy (implicated_via_orthology) | 6.03e-05 | 3 | 133 | 2 | DOID:0060762 (implicated_via_orthology) | |
| Disease | Cholestasis, benign recurrent intrahepatic 1 | 6.03e-05 | 3 | 133 | 2 | C4551899 | |
| Disease | Cobblestone Lissencephaly | 6.03e-05 | 3 | 133 | 2 | C0431376 | |
| Disease | Glycosylphosphatidylinositol deficiency | 6.03e-05 | 3 | 133 | 2 | C1853205 | |
| Disease | Bipolar Disorder | HTR1B PSEN2 ABCA13 WFS1 GRIK4 CHRM2 ADRA1A SLC18A1 GPRC5D CNR2 | 6.37e-05 | 477 | 133 | 10 | C0005586 |
| Disease | Familial intrahepatic cholestasis of pregnancy | 1.20e-04 | 4 | 133 | 2 | C3489728 | |
| Disease | Cholestasis, progressive familial intrahepatic 1 | 1.20e-04 | 4 | 133 | 2 | C4551898 | |
| Disease | anxiety disorder (implicated_via_orthology) | 1.29e-04 | 22 | 133 | 3 | DOID:2030 (implicated_via_orthology) | |
| Disease | Mental Depression | 1.60e-04 | 254 | 133 | 7 | C0011570 | |
| Disease | Cocaine Abuse | 2.82e-04 | 127 | 133 | 5 | C0009171 | |
| Disease | Cholangitis, Sclerosing | 2.99e-04 | 6 | 133 | 2 | C0008313 | |
| Disease | Periventricular Nodular Heterotopia | 4.17e-04 | 7 | 133 | 2 | C1868720 | |
| Disease | Cocaine Dependence | 4.28e-04 | 139 | 133 | 5 | C0600427 | |
| Disease | Cholestasis of pregnancy | 5.55e-04 | 8 | 133 | 2 | C0268318 | |
| Disease | Primary sclerosing cholangitis | 5.55e-04 | 8 | 133 | 2 | C0566602 | |
| Disease | Developmental delay (disorder) | 6.22e-04 | 37 | 133 | 3 | C0424605 | |
| Disease | anterior uveitis (biomarker_via_orthology) | 7.11e-04 | 9 | 133 | 2 | DOID:1407 (biomarker_via_orthology) | |
| Disease | Coronavirus infectious disease (implicated_via_orthology) | 7.11e-04 | 9 | 133 | 2 | DOID:0080599 (implicated_via_orthology) | |
| Disease | Unipolar Depression | 1.17e-03 | 259 | 133 | 6 | C0041696 | |
| Disease | Epilepsy | 1.52e-03 | 109 | 133 | 4 | C0014544 | |
| Disease | phoneme awareness | 1.77e-03 | 14 | 133 | 2 | EFO_0021812 | |
| Disease | Cocaine-Related Disorders | 1.97e-03 | 117 | 133 | 4 | C0236736 | |
| Disease | response to carboplatin | 2.30e-03 | 58 | 133 | 3 | GO_0097328 | |
| Disease | copine-1 measurement | 2.62e-03 | 17 | 133 | 2 | EFO_0008102 | |
| Disease | Moyamoya Disease | 2.62e-03 | 17 | 133 | 2 | C0026654 | |
| Disease | Disorder of eye | 2.79e-03 | 212 | 133 | 5 | C0015397 | |
| Disease | C-X-C motif chemokine 16 measurement | 2.94e-03 | 18 | 133 | 2 | EFO_0010911 | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 3.28e-03 | 19 | 133 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 3.28e-03 | 19 | 133 | 2 | DOID:10003 (implicated_via_orthology) | |
| Disease | glaucoma (is_marker_for) | 3.63e-03 | 20 | 133 | 2 | DOID:1686 (is_marker_for) | |
| Disease | energy expenditure measurement | 3.63e-03 | 20 | 133 | 2 | EFO_0008005 | |
| Disease | lung cancer | 4.00e-03 | 21 | 133 | 2 | MONDO_0008903 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VLLLTLYTVLGPWFF | 486 | Q0P6H9 | |
| LDLPLQCYNWTLTLG | 601 | Q76B58 | |
| WLGYLNSLINPIIYT | 356 | P28222 | |
| WVISLLVSLPQIIYG | 156 | O00574 | |
| AAAWSLFQQLLYGLI | 976 | Q9NY47 | |
| FLAWLGYLNSLINPL | 331 | P30939 | |
| PYWLLVFLAALNALL | 291 | Q9H2F3 | |
| LLVLGLIELSWNTYP | 386 | Q92685 | |
| VFWLGYLNSCINPII | 311 | P35348 | |
| PLFVQLILENIWSLY | 291 | Q7Z2Z2 | |
| ILGALTVFYPSIALW | 96 | Q14330 | |
| WLGYVNSLINPLLYT | 331 | P28566 | |
| LVWTPLLAAYSIGLQ | 896 | Q9Y6D5 | |
| TGPWSLILILFSVQY | 21 | P53420 | |
| GGLFVLTKYWQQIPL | 2891 | Q86UQ4 | |
| LIIGAWNYPFVLTIQ | 106 | P51648 | |
| WNYPFVLTIQPLIGA | 111 | P51648 | |
| AILLAFIITWAPYNV | 391 | P08172 | |
| LFWAPYNIVLLLNTF | 246 | P51681 | |
| ASNALRQPYIWLTII | 1136 | O43520 | |
| IPNDYLLSWLLFIAF | 186 | P34972 | |
| TLWLFSNNLSTIYPG | 86 | Q86UN3 | |
| SYFTIWLNLELLLPV | 71 | Q8NCC3 | |
| VPLLNSLAAYGWQLT | 391 | Q14699 | |
| QIILAIYFLWQNLGP | 436 | O15438 | |
| IYFLWQNLGPSVLAG | 441 | O15438 | |
| LLSPLLSLGQYLWAA | 846 | Q8WUM0 | |
| TYIQWLFPLREQGLN | 156 | Q5TC84 | |
| FLAVLLYLSAAVIWP | 236 | A6NDP7 | |
| QLVASPLLGVWYFLG | 106 | Q567V2 | |
| TLLSQNFSVYLTWLP | 31 | Q8IU57 | |
| GYLQPWAIILISLAA | 1656 | E2RYF6 | |
| WLVTLSSAIYGLQPN | 281 | Q5T848 | |
| LSILYSIGSKPLQIW | 11 | Q9Y6A4 | |
| VWGLELILFNSPEYQ | 86 | P54252 | |
| IYIFIPQNVQVLLWS | 311 | Q9UPZ3 | |
| LNKPYLFSVLLGAWQ | 96 | Q9GZN4 | |
| TEPSILNNYLIWNLV | 426 | P0DPD6 | |
| VFQSLEAYWPGLQSL | 311 | Q9BV94 | |
| LNSWYGFALALLIII | 196 | Q8NH59 | |
| LLGVNNLEFNWLLPY | 346 | Q5XG92 | |
| SYWLELLGPNNSLVA | 91 | P56597 | |
| LVQLPQHGQLYLWGT | 1546 | Q5H8C1 | |
| AIVLWLGYANSALNP | 271 | P25021 | |
| AILLPFVYLTAQVWI | 16 | Q9HBW1 | |
| VNLYTVNAPWLFSLL | 451 | Q8WTR4 | |
| LLYGTWIVAILQSTP | 151 | Q96P66 | |
| QYSNWLLAGNLALSP | 521 | Q9P215 | |
| WQYVLLIPSVLQEGS | 11 | Q6IE36 | |
| LWLLSSNVYRNPFAI | 46 | Q86SM8 | |
| ANLTWLNGCINPVLY | 356 | Q9NQS5 | |
| ISLTWLLSPYIGNLS | 271 | Q7Z442 | |
| QLLQWVGDFVLYLLA | 616 | Q9Y2X0 | |
| IYGWQLTLLLLAVVP | 851 | P21439 | |
| GLPSVFYWSLQPLLN | 211 | Q86SM5 | |
| LGPILATILAQSYSW | 151 | O43826 | |
| NLQLAIIWYFSPVST | 706 | Q93033 | |
| WGATVITNLLSAIPY | 141 | P00156 | |
| LVTNAWVFLLLYIVP | 246 | Q9NZD1 | |
| GLNPSLWYIIGIQFL | 1076 | P54289 | |
| FWTPYNLTILISVFQ | 251 | P32246 | |
| TTGIILQWLQSDPYL | 311 | Q9H2U1 | |
| WILLLLSLYPGFTSQ | 26 | P18507 | |
| SFQIYVLQAGAWPLT | 506 | Q13617 | |
| FTWLGYLNSLINPII | 341 | P28221 | |
| LLLLLVQGLNCFWSY | 306 | Q6ZMG9 | |
| NTGILFLPWGYDISQ | 176 | Q9C0D9 | |
| NLQIYGVLGLFWTLN | 441 | Q53GD3 | |
| ENSPNYGLLLLWASL | 261 | Q9NYL5 | |
| YGLLLLWASLSNAVP | 266 | Q9NYL5 | |
| LTGYEVWLGTLFQNP | 531 | P26927 | |
| LLVNQYSLGNSLWFP | 586 | Q16099 | |
| LTGLPWSLYNTFVIE | 136 | O75844 | |
| LTGIAYSLPHWQLLF | 286 | Q9Y267 | |
| YSLPHWQLLFLVGGI | 291 | Q9Y267 | |
| AQYLPGWTVLFLSVL | 416 | A6NKX4 | |
| GTYNSLLIISWLPVL | 361 | O00237 | |
| YSLVWFISPILGFLL | 156 | Q9Y2W3 | |
| FPLGILLLFWVSYVT | 6 | Q08AI6 | |
| GAVLVFLPGWNLIYT | 651 | Q08211 | |
| PNGITLDLLSQRLYW | 586 | Q14114 | |
| YTTSSIPQLLVNLWG | 76 | O76001 | |
| VLLLNWYSTVLNPAF | 61 | P59537 | |
| VLLLNWYSTVLNPAF | 61 | P59539 | |
| ALLLNWYLTVLNPAF | 61 | P59544 | |
| AYQASNLPSLELLIW | 61 | Q8N808 | |
| WIYFVNFLGTLAVLP | 581 | Q496J9 | |
| LQSLALTWYSLSFIP | 131 | O95562 | |
| LQVGLNTIADLWYLF | 251 | Q9UKY4 | |
| SIPGFLVNYILVLWH | 111 | Q4G0N8 | |
| FPFIISWISQLNVIY | 626 | Q4G0N8 | |
| PTWAQTLIFQHLLLY | 1121 | A0AVI2 | |
| TESVLYLNGLWLPLV | 421 | O95255 | |
| FVYLWQLLGPSALTA | 441 | O95255 | |
| LAWLLAFVYNLPHTV | 36 | Q9BY78 | |
| FLIIVPLSTLSNWAY | 806 | P51532 | |
| VSSWGGYVFLINLIP | 206 | P46977 | |
| TDLLSAIQFWLLYAP | 241 | Q96M53 | |
| SFIPQQYFWLLVLSR | 186 | Q8IVW8 | |
| WNGLTANLLKIVPYF | 266 | Q8WUT9 | |
| QNPVRLWQLLGGTFY | 86 | Q9UQ90 | |
| ITSYLLQLLWPSNPG | 861 | Q12769 | |
| FWLGLLYLVSPLENE | 181 | Q9NPE6 | |
| LGFLSLWYPVQLVRS | 216 | Q9BX79 | |
| NSLYSVWPLVFLGIG | 201 | Q7Z7B1 | |
| LGLVLPLWSDTQVYL | 161 | Q8TE77 | |
| AILLAFIITWTPYNI | 446 | P08912 | |
| VGLALLTLIINPYWT | 236 | Q9UBY8 | |
| LNPEWLVNYFGSLSV | 646 | Q00610 | |
| AEWVTLGLNIPLLFY | 86 | Q6PI25 | |
| QEWLTLGLNVPLLFY | 86 | Q8TBE1 | |
| LGIPQSWRLYLVNLC | 666 | Q63HN8 | |
| LGPWNIIFFITYEQL | 306 | O95258 | |
| LSWGPYNFTLFLQTL | 236 | P46094 | |
| LLNAWRTPYGASIFQ | 721 | Q04724 | |
| LQQLYASLPVNGELW | 1411 | Q86UP3 | |
| YTKLWTPLLQSLIGL | 861 | P55060 | |
| YLALANQVLSWNFLP | 226 | Q9C0E2 | |
| VLLLGWLFAPVYLTA | 106 | P31639 | |
| PWTQVGFSLLFLYLG | 21 | Q6P1M0 | |
| PLALWSIIVNILLYF | 16 | Q96CE8 | |
| SAWGGYVFIINLIPL | 261 | Q8TCJ2 | |
| QVYQLVLPGSELLLW | 156 | Q9H9D4 | |
| PFLTTEVNNLGWLSY | 46 | Q9BRV3 | |
| GNLLLILQYIWSFEL | 551 | Q9H5I5 | |
| QRWLTYYPSGQLLIV | 761 | P52849 | |
| YPTLLLTVWNFGAVG | 201 | P49810 | |
| YIKPGLSLSVALLWQ | 216 | Q8N816 | |
| LGIPLTSQAGIYWLL | 511 | P48067 | |
| LQRLIGNESFALPYW | 231 | P40126 | |
| LITHLGLPQWQYAFT | 196 | Q68CL5 | |
| YLVNNTPLNWLVGPF | 391 | Q99541 | |
| FLSTELAWLLPYNGV | 656 | Q8WUA4 | |
| GPILDNYISALSALW | 351 | O43294 | |
| QVWIALYNLLLSPEA | 261 | O75800 | |
| LTFNYLLPVNAWLLL | 281 | Q6ZXV5 | |
| QVLWAYVGLLSNPQA | 501 | Q6NUS6 | |
| GWLLTPNIYLSELFG | 81 | Q9H3S5 | |
| ILLEPYLFWQILNGQ | 861 | P01266 | |
| TRFQGVYLPLLWEQS | 556 | Q9UGI0 | |
| TDPYLGLLLQQCWAT | 356 | Q12836 | |
| TNLAAYVPLLTQGWA | 1181 | P49815 | |
| SLLLVYGSWFQPTIE | 346 | Q15061 | |
| WQLGLAFLPASVSYL | 336 | P54219 | |
| LNWPYLKVLGQTFIT | 476 | O76024 |